Clinical and microbiological evaluation in patients with Fournier’s gangrene-Reference-Cited by-同舟云学术

Clinical and microbiological evaluation in patients with Fournier’s gangrene

Published:2023-12-05 Issue:3 Volume:19 Page:229-236
ISSN:1734-1531
Container-title:Pediatria i Medycyna Rodzinna
language:
Short-container-title:Pediatr Med Rodz

Author:

Grabińska Agnieszka¹^ORCID,Durma Adam Daniel²^ORCID,Michalczyk Łukasz³^ORCID,Durma Anna Celina⁴^ORCID,Grabińska Anna⁵^ORCID,Syryło Tomasz¹^ORCID,Ząbkowski Tomasz¹^ORCID

Affiliation:

1. Department of General, Functional and Oncological Urology, Military Institute of Medicine – National Research Institute, Warsaw, Poland

2. Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland

3. Department of Urology, District Hospital, Kozienice, Poland

4. Department of Diabetology and Internal Medicine, Medical University of Warsaw – National Research Institute, Warsaw, Poland

5. Department of Gastroenterology and Internal Medicine, Military Institute of Medicine – National Research Institute, Warsaw, Poland

Abstract

Introduction: Necrotising fasciitis (Fournier’s gangrene) is a bacterial inflammation of the subcutaneous tissues and skin, involving the urogenital area. The treatment is complex, with a high risk of systemic infection. A key aspect of treatment is antibiotic therapy. Materials and methods: The analysis involved 30 hospitalised patients with Fournier’s gangrene. An attempt was made to determine the relationship between laboratory parameters, types of pathogens, patterns of antibiotic susceptibility/resistance, and treatment outcomes. Results: The average value of Fournier’s Gangrene Severity Index (FGSI) was 4.37 ± 2.87. In the study group, a total of 18 (60%) patients had an infection caused by a single bacterial strain, while 12 (40%) had infections caused by multiple strains. The most commonly identified bacteria was Escherichia coli (53.33%) – 50% of monocultural infections and 58.33% of polyculture infections. The majority of bacteria were sensitive to piperacillin–tazobactam – 22 (73.33%) patients, clindamycin – 20 (66.66%) patients, and metronidazole – 18 (60%) patients. The highest percentage of antibiotic resistance was observed for cefuroxime – 19 (63.33%) patients, ciprofloxacin – 19 (63.33%) patients, and ceftriaxone – 17 (56.66%) patients. The average hospitalisation length was 30.03 ± 23.01 days. The overall mortality rate was 13.33% (n = 4). No correlation was found between the type of pathogen, hospitalisation length or mortality. No differences were observed in the results of laboratory parameters, FGSI, or length of hospitalisation in the analysed subgroups. Conclusions: Effective treatment of Fournier’s gangrene requires performing a wound swab culture as quickly as possible and implementing a targeted antibiotic therapy. There is no single laboratory parameter that can predict treatment outcomes and patient prognosis. There are no differences in the clinical course and prognosis between multibacterial and monobacterial infections.

Publisher

Medical Communications Sp. z.o.o.

Subject

Family Practice,Pediatrics, Perinatology and Child Health

Reference40 articles.

1. Chennamsetty A, Khourdaji I, Burks F et al.: Contemporary diagnosis and management of Fournier’s gangrene. Ther Adv Urol 2015; 7: 203–215.

2. Sorensen MD, Krieger JN, Rivara FP et al.: Fournier’s gangrene: population based epidemiology and outcomes. J Urol 2009; 181: 2120–2126.

3. Shyam DC, Rapsang AG: Fournier’s gangrene. Surgeon 2013; 11: 222–232.

4. Rodríguez Alonso A, Pérez García MD, Núñez López A et al.: Gangrena de Fournier: aspectos anátomo-clínicos en el adulto y en el niño. Actualización terapéutica [Fournier’s gangrene: anatomo-clinical features in adults and children. Therapy update]. Actas Urol Esp 2000; 24: 294–306.

5. Montoya Chinchilla R, Izquierdo Morejon E, Nicolae Pietricicâ B et al.: Gangrena de Fournier. Análisis descriptivo de 20 casos y revisión de la bibliografía científica [Fournier’s gangrene. Descriptive analysis of 20 cases and literature review]. Actas Urol Esp 2009; 33: 873–880.